Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-03-07 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
第五届董事会第二十一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by 盈康生命科技股份有限公司. It details the convening of the 21st temporary meeting of the 5th board, the attendance, the approval of a management agreement with related parties, and the voting results. It includes references to independent directors' opinions and a securities firm's verification opinion. The document is short (1344 characters) and primarily serves to announce the board's decision rather than provide detailed financial data or a full report. It does not contain financial statements or comprehensive management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2022-03-07 Chinese
关于公司办公地址、网址及电子邮箱变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about changes in the company's office address, website, and email. It does not contain financial data, regulatory certifications, or detailed report content. It is not an annual report, earnings release, or any financial filing. It is also not related to board or management changes, voting results, or capital changes. The document is a general regulatory announcement about company contact information changes, which fits best under Regulatory Filings (RNS). The document length is short (594 characters), and it is a straightforward announcement without financial or governance details.
2022-02-22 Chinese
关于实际控制人的一致行动人增持公司股份及增持股份计划的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the increase in shareholding by a related party (an acting-in-concert party of the actual controller) in the company. It details the share purchase plan, the amount, timing, and risks involved. It does not contain financial statements or performance data, nor is it a report or presentation. It is a notification of a change in major shareholding levels, consistent with the definition of Major Shareholding Notification (MRQ). The document length is short (2175 characters), and it is not an announcement of a report publication or a certification. Therefore, the appropriate classification is MRQ.
2022-02-14 Chinese
上海荣正投资咨询股份有限公司关于公司2022年限制性股票激励计划授予相关事项之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is an Independent Financial Advisor Report related to the 2022 Restricted Stock Incentive Plan of Yingkang Life Technology Co., Ltd. It details the approval procedures, grant conditions, stock allocation, and the impact on financial results. It is not a full annual or interim financial report, nor an earnings release or regulatory filing. It is a specialized advisory report on stock incentive plan grants, which fits the category of Audit Report / Information (AR) as it includes financial advisory and verification related to accounting and stock incentive matters but is not a full annual report or earnings release. The document length (9594 characters) and detailed content support this classification with high confidence. FY 2022
2022-02-08 Chinese
北京市金杜（青岛）律师事务所关于公司2022年限制性股票激励计划授予事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2022 restricted stock incentive plan grant for Yingkang Life Technology Co., Ltd. It discusses the legal compliance, approvals, authorizations, and conditions related to the stock incentive plan. The document is not a financial report, earnings release, or management discussion. It is a legal opinion related to a capital incentive plan, which is a corporate governance and regulatory compliance matter. It does not announce voting results, nor is it a proxy statement or remuneration report. It is not a general regulatory filing or announcement of a report publication. Given the nature of the document as a legal opinion on a stock incentive plan grant, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories but involve regulatory compliance and legal opinions.
2022-02-08 Chinese
2022年限制性股票激励计划授予的激励对象名单（授予日）
Remuneration Information Classification · 95% confidence The document is titled as a list of recipients for a 2022 restricted stock incentive plan, detailing the allocation of restricted shares among directors, senior management, and core employees. It includes names, positions, and share quantities. The content focuses on equity incentive distribution rather than financial results, governance rules, or meeting materials. It is not a full financial report, earnings release, or management discussion. It is also not a brief announcement or a certification. The document is a detailed disclosure related to share-based compensation, which aligns best with Remuneration Information filings that report on executive and director compensation plans and stock incentives.
2022-02-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.